Peptide-based immunotherapy of experimental autoimmune encephalomyelitis without anaphylaxis

Administration of peptide antigens in tolerogenic form holds promise as a specific treatment for autoimmune and allergic disorders. However, experiments in rodent autoimmune models have highlighted the risk of anaphylaxis in response to systemic peptide application once the aberrant immune response...

Descripción completa

Detalles Bibliográficos
Autores principales: Leech, Melanie D, Chung, Chen-Yen, Culshaw, Abigail, Anderton, Stephen M
Formato: Texto
Lenguaje:English
Publicado: WILEY-VCH Verlag 2007
Materias:
Clinical immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699421/
https://www.ncbi.nlm.nih.gov/pubmed/18000952
http://dx.doi.org/10.1002/eji.200737148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699421/
https://www.ncbi.nlm.nih.gov/pubmed/18000952
http://dx.doi.org/10.1002/eji.200737148

Ejemplares similares